|
Name |
Chaetocin, 2-de(hydroxymethyl)-19'-deoxy-6,6'-dihydroxy-2-(1-hydroxyethyl)-, (6S,6'S,7S,7'S)-
|
Molecular Formula | C31H30N6O7S4 | |
IUPAC Name* |
(1S,2S,3R,11R)-2-hydroxy-3-[(1S,2S,3S,11S,14S)-2-hydroxy-14-(1-hydroxyethyl)-18-methyl-13,17-dioxo-15,16-dithia-10,12,18-triazapentacyclo[12.2.2.01,12.03,11.04,9]octadeca-4,6,8-trien-3-yl]-14,18-dimethyl-15,16-dithia-10,12,18-triazapentacyclo[12.2.2.01,12.03,11.04,9]octadeca-4,6,8-triene-13,17-dione
|
|
SMILES |
CC([C@]12C(=O)N3[C@H]4[C@]([C@@H]([C@@]3(C(=O)N1C)SS2)O)(C5=CC=CC=C5N4)[C@@]67[C@@H]([C@]89C(=O)N(C(C(=O)N8[C@H]6NC1=CC=CC=C71)(SS9)C)C)O)O
|
|
InChI |
InChI=1S/C31H30N6O7S4/c1-13(38)29-25(44)37-21-28(15-10-6-8-12-17(15)33-21,19(40)31(37,48-46-29)24(43)35(29)4)27-14-9-5-7-11-16(14)32-20(27)36-22(41)26(2)34(3)23(42)30(36,18(27)39)47-45-26/h5-13,18-21,32-33,38-40H,1-4H3/t13?,18-,19-,20+,21-,26?,27-,28+,29-,30-,31-/m0/s1
|
|
InChIKey |
PRYIVLXRWBBBJH-SVONFVJMSA-N
|
|
Synonyms |
Sch 52900; 174285-71-3; Chaetocin, 2-de(hydroxymethyl)-19'-deoxy-6,6'-dihydroxy-2-(1-hydroxyethyl)-, (6S,6'S,7S,7'S)-
|
|
CAS | 174285-71-3 | |
PubChem CID | 132472058 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 726.9 | ALogp: | 1.0 |
HBD: | 5 | HBA: | 13 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 267.0 | Aromatic Rings: | 12 |
Heavy Atoms: | 48 | QED Weighted: | 0.28 |
Caco-2 Permeability: | -5.877 | MDCK Permeability: | 0.00001070 |
Pgp-inhibitor: | 0.877 | Pgp-substrate: | 0.213 |
Human Intestinal Absorption (HIA): | 0.553 | 20% Bioavailability (F20%): | 0.986 |
30% Bioavailability (F30%): | 0.996 |
Blood-Brain-Barrier Penetration (BBB): | 0.143 | Plasma Protein Binding (PPB): | 79.11% |
Volume Distribution (VD): | 0.921 | Fu: | 10.99% |
CYP1A2-inhibitor: | 0.014 | CYP1A2-substrate: | 0.097 |
CYP2C19-inhibitor: | 0.936 | CYP2C19-substrate: | 0.941 |
CYP2C9-inhibitor: | 0.974 | CYP2C9-substrate: | 0.117 |
CYP2D6-inhibitor: | 0.05 | CYP2D6-substrate: | 0.075 |
CYP3A4-inhibitor: | 0.945 | CYP3A4-substrate: | 0.986 |
Clearance (CL): | 5.762 | Half-life (T1/2): | 0.024 |
hERG Blockers: | 0 | Human Hepatotoxicity (H-HT): | 0.083 |
Drug-inuced Liver Injury (DILI): | 0.987 | AMES Toxicity: | 0.012 |
Rat Oral Acute Toxicity: | 0.915 | Maximum Recommended Daily Dose: | 0.78 |
Skin Sensitization: | 0.918 | Carcinogencity: | 0.486 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.006 |
Respiratory Toxicity: | 0.429 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC004849 | 0.894 | D0SP3D | 0.231 | ||||
ENC003490 | 0.882 | D09NNH | 0.231 | ||||
ENC003176 | 0.878 | D01TSI | 0.231 | ||||
ENC003382 | 0.859 | D0V3ZA | 0.225 | ||||
ENC003588 | 0.829 | D0W7RJ | 0.219 | ||||
ENC004848 | 0.669 | D0E0RY | 0.219 | ||||
ENC001500 | 0.577 | D0V9WF | 0.213 | ||||
ENC002358 | 0.527 | D0J5YC | 0.208 | ||||
ENC003992 | 0.428 | D0O5WP | 0.208 | ||||
ENC003530 | 0.414 | D0K4CQ | 0.207 |